At IBA we dare to develop innovative solutions pushing back the limits of science. We share ideas and know-how with our customers, our partners and leading experts to bring new solutions for the diagnosis and treatment of cancer and for the benefits of patients. We care of the well-being of patients and stakeholders as it is together that we complete our mission to Protect, Enhance and Save lives.
The Shift aide ses membres à utiliser le cadre international des Objectifs de développement durable de l'ONU pour définir leurs ambitions sociales.
13. Climate action
By signing the COP21 engagement letter, we commit to take voluntary action to reduce environmental and carbon footprints. We implement this by setting targets to reduce our current own GHG emissions and/or energy consumption, while also collaborating in supply chains and at sectorial levels. We agree on the need for inspirational and meaningful global action and aligned messaging. We will act as ambassadors for climate action, focusing on solutions and economic opportunities. We will help raise public awareness. We will actively manage climate risks and incorporate them in decision making — not least to realize growth opportunities. We will take steps to implement effective strategies to strengthen not only our companies’ but also societal resilience.
3. Good health
IBA, through its core business, works in this direction. Our mission is to Protect, Enhance and Save Lives. IBA develops, manufactures and supports medical devices and software solutions for cancer treatment by proton beam therapy, for cancer diagnosis and for patient quality assurance (Dosimetry). In addition, the company partners with healthcare leaders to provide cancer clinics and academic health centers with a fully-integrated approach of the patient flow.